The introduction of Retatrutide in the United Kingdom is generating significant buzz within the weight loss community. This groundbreaking dual compound – targeting both GLP-1 and GIP – suggests a potentially new solution to addressing obesity . Until recently, options have been restricted for many, and Retatrutide represents a hopeful prospect